Farmaco

by Jerry Avorn Knopf New York, 2004. 457 pp. $27.50, C$39.95. ISBN 0-375-41483-5.

Pharmacotherapy for pregnant women with addictions

Methods to assess intended effects of drug treatment in observational studies are reviewed

Aspirin Sensitivity: Implications for Patients With Coronary Artery Disease

Limited data suggest that the long-term use of stimulants in children with attention-deficit hyperactivity disorder is effective and safe

autori Piergiorgio Zuccaro [et al.]. - Roma : Istituto Superiore di Sanita, 2002. - 75 p. ; 23 cm. ...

Geneva : World Health Organization, 2004. - 263 p. : ill. ; 24 cm. ...

edited by Chandrahas G. Sahajwalla. - New York, N.Y. ; Basel : Dekker, 2004. - xix, 596 p. : ill. ; 24 cm. ...

Phase I and pharmacokinetics. Phase I trial of intravenous aviscumine (rViscumin) in patients with solid tumors: a study of the European Organization for Research and Treatment of Cancer New Drug Development Group

Application of proteomic technologies to tumor analysis

Toward an integrative systems toxicology

The effects of EU enlargement on European drug policy

The Economics of Follow-on Drug Research and Development: Trends in Entry Rates and the Timing of Development

Changes in the Costs of Treating Mental Health Disorders: An Overview of Recent Findings

Global Principles for Better Healthcare

Toxicity of nitrazepam in the elderly: a report from the Boston Collaborative Drug Surveillance Program

The changing scene of the regulation of medicines in the UK. Paper from The Use of Medicines: Regulation & Clinical Pharmacology in the 21st Century Symposium December 2003

The use of pharmacokinetic and pharmacodynamic data in the assessment of drug safety in early drug development

Iron Deficiency in Children With Attention-Deficit/Hyperactivity Disorder

Pharmacological Cardioversion of Atrial Fibrillation: Current Management and Treatment Options

Can We Ensure the Safe Use of Known Human Teratogens?: Introduction of Generic Isotretinoin in the US as an Example

Benefit-Risk Assessment of Atypical Antipsychotics in the Treatment of Schizophrenia and Comorbid Disorders in Children and Adolescents

Tardive Dyskinesia Risks and Metoclopramide Use Before and After U.S. Market Withdrawal of Cisapride

Potential for Conflict of Interest in the Evaluation of Suspected Adverse Drug Reactions: Use of Cerivastatin and Risk of Rhabdomyolysis

Postmarketing Surveillance-Lack of Vigilance, Lack of Trust

Authors' Reply to Bayer's Response to Potential for Conflict of Interest in the Evaluation of Suspected Adverse Drug Reactions: Use of Cerivastatin and Risk of Rhabdomyolysis

Acute Colchicine Intoxication During Clarithromycin Administration

First Patient-Centered Drug Information Service in Germany-A Descriptive Study

The Medicinal Uses of Cannabis and Cannabinoids

Early Postmarketing Drug Safety Surveillance: Data Mining Points to Consider

Therapeutic Risk Management Interventions: Feasibility and Effectiveness

Antithrombotic Therapy for Acute Coronary Syndromes

Identification of Serious Drug-Drug Interactions: Results of the Partnership to Prevent Drug-Drug Interactions

The state control of medicines: the first 3000 years

[7. ed.]. - Amsterdam [etc.] : IOS Press ; Tokyo : Ohmsha, 2003. - 151 p. ; 30 cm.

Editor(s): Brian L. Strom; Print ISBN 0 4718 9925 9

Editor(s): Ronald D. Mann, Elizabeth B. Andrews; Print ISBN 0 4714 9441 0

Editor(s): Josef Kolman, Paul Meng, Graeme Scott; Print ISBN 0 4719 6936 2

Shayne C. Gad; Print ISBN 0 4714 0727 5

Giuseppe Traversa [et al.]. - Roma : Istituto Superiore di Sanita. Servizio per le Attivita Editoriali, 2004. - 100 p. : ill. ; 29 cm. (In testa al front.: Istituto Superiore di Sanità)

edited by Beverly A. Teicher, Paul A. Andrews. - 2. ed. - Totowa, N.J. : Humana Press, 2004. - xiii, 450 p. : ill. ; 26 cm. + 1 CD-ROM ; 12 cm...

edited by Jurgen Bajorath. - Totowa, N.J. : ill. ; 24 cm. ...

Supplement 5.1 / published in accordance with the Convention on the Elaboration of a European Pharmacopoeia. - 5. ed. - Strasbourg : Council of Europe, 2004. - P. xxi-xxii, 2781-3086 ; 30 cm.

edited by William D. Figg and Howard L. McLeod. - Totowa, N.J. : Humana Press, 2004. - xiv, 623 p. : ill. ; 26 cm. + 1 CD-ROM ; 12 cm. ...

Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels

Methadone—metabolism, pharmacokinetics and interactions

Adverse drug events in two emergency departments in Naples, Italy: an observational study

Alcohol as a certified cause of death in a 'middle England' population 1979–1999: database study

Pharmacoepidemiology in Safety Evaluations of Newly Approved Medications

Vaccinovigilance in Europe--need for timeliness, standardization and resources

Business and Medicine: Merck's Recall of Rofecoxib - A Strategic Perspective

Torino : Bradipolibri, 2004- . - 142 p. : ill ; 21 cm. (Tit. orig.: Massacre a la chaine ISBN: 8888329064)

Factors that influence spontaneous reporting of adverse drug reactions: a model centralized in the medical professional

Animal testing and alternative approaches for the human health risk assessment under the proposed new European chemicals regulation

Drug interaction between St John's Wort and quazepam

Undeclared exposure to St. John's Wort in hospitalized patients

Acetylcholinesterase inhibitors: novel activities of old molecules

Expecting the Unexpected - Drug Safety, Pharmacovigilance, and the Prepared Mind

EMEA and the evaluation of health-related quality of life data in the drug regulatory process

New insights on attention-deficit/hyperactivity disorder pharmacogenomics

Pharmacogenetics of antihypertensive treatment

Recent advances in pharmacogenetic approaches to anticancer drug development

Grading quality of evidence and strength of recommendations

An Omics view of drug development

Pharmacogenetics in drug development: Regulatory and clinical considerations

Application of expression genomics in drug development and genomic medicine

Use of herbal drugs in pregnancy: a survey among 400 Norwegian women

Current national initiatives about drug policies and cost control in Europe: the Italy example

Introduction to the symposium: what evidence based medicine is and what it is not

Toremifene and tamoxifen are equally effective for early-stage breast cancer: first results of International Breast Cancer Study Group Trials 12-93 and 14-93

Schism and heresy in the development of orthodox medicine: the threat to medical hegemony